Alto Imaging
Alto Imaging is a New South Wales medical diagnostic imaging practice operating ten centres across the Hunter region, delivering MRI, CT, X-Ray, ultrasound, nuclear medicine, PET/CT, mammography, lung screening, and therapeutic injections to patients and referring doctors, now owned by PRP Diagnostic Imaging.
- Company typePrivate
- Founded-
- HeadquartersGlendale, Australia
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Alto Imaging does
Alto Imaging is a New South Wales-based medical diagnostic imaging practice operating ten physical centres across the Hunter region, Newcastle, Port Stephens, Hunter Valley, and Lake Macquarie. Its service portfolio spans twelve modalities: MRI (Titan MRI machine positioned for claustrophobic and difficult-to-scan patients), digital X-Ray, CT, ultrasound (including MSK, vascular, and guided procedures), nuclear medicine, PET/CT (lowest achievable radiation doses), mammography, DXA bone mineral density, OPG dental imaging, and two therapeutic injection lines — Euflexxa (TGA-approved 1% sodium hyaluronate) and platelet-rich plasma (PRP). It also delivers low-dose CT lung cancer screening under Australia's National Lung Cancer Screening Program for eligible patients aged 50-70.
The business operates a hybrid go-to-market combining direct-to-consumer access (online booking, phone, walk-in for select services) with a healthcare-provider referral channel routed through an eReferral system and PACS/XirriX image portals. Patients and referrer information are now managed through the PRP Diagnostic Imaging network following Alto's November 2025 acquisition by PRP, a 32-practice, 1,000+ professional NSW radiology group. Revenue is generated from professional services — diagnostic imaging scans and therapeutic injections — with the majority bulk-billed to Medicare for eligible procedures, supplemented by the fully government-funded lung screening program and privately-paid therapeutic injections. Customers are individual patients (long-tail, distributed) and referring GPs/specialists who drive demand via clinical referrals rather than enterprise contracts.
Alto Imaging firmographics
Firmographics- Name
- Alto Imaging
- Legal name
- Alto Imaging
- Website
- https://altoimaging.com.au
- Company type
- Private
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Alto Imaging is a New South Wales medical diagnostic imaging practice operating ten centres across the Hunter region, delivering MRI, CT, X-Ray, ultrasound, nuclear medicine, PET/CT, mammography, lung screening, and therapeutic injections to patients and referring doctors, now owned by PRP Diagnostic Imaging.
- Ownership category
- akta.pro rank
Alto Imaging industry classification
Industry- Product category
- Diagnostic Imaging Services
- NAICS
- Diagnostic Imaging Centers (621512)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA)
- akta.pro secondary industry
- Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)
Keywords
Where Alto Imaging is headquartered
LocationHeadquarters
- HQ city
- Glendale
- HQ country
- Australia
- HQ region
- Oceania
Offices9 records
Markets served
Alto Imaging business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Diagnostic Imaging Services: Revenue generated from providing medical imaging services including MRI, CT, X-Ray, Ultrasound, Nuclear Medicine, PET/CT, Mammography, and Bone Mineral Density scans. Services are bulk-billed to Medicare for eligible procedures.
- Therapeutic Injections: Revenue from providing therapeutic treatments including PRP injections and Euflexxa injections for joint pain management.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Alto Imaging product offering
Product offeringCore offering
Alto Imaging is a medical diagnostic imaging practice that provides twelve distinct services — MRI, X-Ray, CT, Ultrasound, Nuclear Medicine, PET/CT, Mammography, Bone Mineral Density (DXA), OPG dental scans, Lung Cancer Screening, Euflexxa joint injections, and PRP injections — across 10 clinics in the Hunter region and Greater Newcastle, New South Wales. Following November 2025 integration into the PRP Diagnostic Imaging network, the practice retains its brand and teams while gaining access to a 32-practice, 1,000+ professional NSW radiology network for sub-specialty expertise and advanced imaging services.
Product overview
Alto Imaging is a medical imaging service provider offering a comprehensive portfolio of diagnostic imaging services integrated with the broader PRP Diagnostic Imaging network. The company provides twelve distinct diagnostic and treatment services: MRI, X-Ray, CT Scans, Bone Mineral Density Scans, Mammograms, Ultrasound, Nuclear Medicine, PET/CT, Lung Cancer Screening, OPG X-Rays, Euflexxa injections, and PRP Injections. Alto Imaging has joined the PRP network, expanding access to advanced imaging services across the Hunter and Greater Newcastle regions through 10 locations. The services range from standard diagnostic imaging (MRI, CT, X-Ray, Ultrasound) to specialized screening programs (lung cancer, mammography, bone density) and therapeutic treatments (Euflexxa for joint pain, PRP for tissue repair).
Differentiator
Problem solved
Functional benefit
Products and services
- MRI (Magnetic Resonance Imaging) State-of-the-art MRI imaging service providing detailed internal body scans for accurate medical diagnosis, using a Titan MRI machine with superior comfort design that accommodates patients who cannot tolerate conventional MRI machines.
- X-Ray Digital X-ray imaging service using modern digital technology that produces detailed images in seconds, easily shareable with radiologists and referring doctors.
- CT Scans Computed tomography scanning service providing comprehensive, reliable CT scans with precision and care, offering gap-free Medicare eligible procedures.
- Bone Mineral Density (BMD) Scans DXA (Dual Energy X-ray Absorptiometry) bone densitometry service, the gold standard for osteoporosis diagnosis, enabling early detection of bone thinning before fractures occur.
- Mammograms High-resolution mammography service for breast health screening and early detection of breast cancer, with dedicated women's health specialists.
- Ultrasound Diagnostic ultrasound imaging service offering examinations including abdomen, renal, neck/thyroid, breast, musculoskeletal, gynecological, obstetrics, ultrasound-guided biopsy and injections, and vascular studies.
- Nuclear Medicine Nuclear medicine scanning service using radioactive tracers for diagnostic and therapeutic purposes, with low radiation doses comparable to CT scans and X-rays.
- PET/CT Combined Positron Emission Tomography and Computed Tomography scanning service providing diagnostic insight for cancer treatment, biopsy guidance, and treatment monitoring, using a latest-technology scanner with the lowest possible radiation dose.
- Lung Cancer Screening Free National Lung Cancer Screening Program service offering low-dose CT scans every two years to eligible Australians aged 50-70, fully funded by the Australian Government with no out-of-pocket cost.
- OPG (Orthopantomogram) X-Rays Panoramic dental X-ray service providing complete imaging of upper and lower jaw, teeth, and temporomandibular joints for comprehensive dental diagnostics including detection of impacted teeth, cysts, and tumors.
- Euflexxa (Sodium Hyaluronate) Injections Non-invasive joint pain treatment using 1% Sodium Hyaluronate injections that supplement synovial fluid for osteoarthritis relief in knees, hips, shoulders, ankles, and elbows; TGA-approved with effects lasting up to six months.
- Platelet-Rich Plasma (PRP) Injections Non-invasive treatment using concentrated platelets and growth factors from the patient's own blood to accelerate tissue repair, promote natural healing, and treat musculoskeletal conditions including osteoarthritis, tendon injuries, and muscle injuries.
Quantifiable outcome
- Lung cancer screening with low-dose CT can detect up to 70% of lung cancers in their early stages
Companies that use Alto Imaging
Customer profileSegments3 records
Ideal customer profiles3 records
Alto Imaging technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Alto Imaging partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PRP Diagnostic ImagingcoreAlto Imaging has joined the PRP Diagnostic Imaging network, one of Australia's largest radiology groups with 32 practices and over 1,000 professionals across NSW. The integration allows Alto to expand access to advanced imaging services, local radiologists, and sub-specialty expertise. Alto's 10 locations in the Hunter region will continue operating under current names and teams, maintaining same booking processes and staff contacts during integration.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Alto Imaging competitors and assessment
Company assessmentDirect peers
- Akumin: North American outpatient diagnostic imaging operator with MRI, CT, PET/CT, and nuclear medicine offerings. Closely aligned in modality portfolio and outpatient-clinic delivery model.
- Integral Diagnostics: ASX-listed Australian radiology operator with regional and metropolitan sites offering MRI, CT, ultrasound, nuclear medicine, and PET/CT. Comparable modality mix and regional-clinic operating model.
- PRP Diagnostic Imaging: Parent network and Australia's large NSW radiology group with 32 practices and 1,000+ professionals. Directly comparable in modality mix, referral workflows, and Medicare bulk-billing model; Alto now operates inside this network.
- Capitol Health: Australian diagnostic imaging group with clinics across Victoria, NSW, and other states. Directly comparable in modality mix (MRI, CT, ultrasound, X-ray, mammography) and referrer-driven workflow.
Broad incumbents
- I-MED Radiology Network: Australia's largest diagnostic imaging network with 250+ clinics nationally. Overlaps directly on MRI, CT, X-ray, ultrasound, nuclear medicine, and PET/CT services, with similar Medicare-driven revenue mix and referrer relationships.
- Healius Limited: ASX-listed healthcare operator with a significant diagnostic imaging division (Lumus Imaging). Operates a comparable modality portfolio and referrer-led model across Australian capital cities and regional centres.
- Radiology Partners: Large US-based radiology practice group with a multi-modality, referrer-led model. Comparable in scale of clinical operations, sub-specialist coverage, and integrated IT/PACS infrastructure for diagnostic imaging.
- Sonic Healthcare: Global diagnostics operator with Australian radiology and pathology services. Comparable in offering MRI/CT imaging alongside broader diagnostics, with national footprint and referrer integration similar to Alto's.
- Unilabs: European diagnostics group offering imaging and laboratory services across multiple geographies. Comparable in offering MRI, CT, and nuclear medicine imaging as part of a multi-modality diagnostics network.
Regional players
- InHealth: UK-based diagnostic imaging and healthcare services provider with comparable multi-modality outpatient services. Operates in a similar referrer-led, government/insurer-funded environment but in the UK market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Alto Imaging social profiles
Digital presenceAlto Imaging compliance and trust
Trust signalCompliance1 record
Alto Imaging financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alto Imaging leadership team
Management profileNumber of profiles
Profiles6 records
Alto Imaging funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alto Imaging M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alto Imaging
What does Alto Imaging do?
Alto Imaging is a medical diagnostic imaging practice that provides twelve distinct services — MRI, X-Ray, CT, Ultrasound, Nuclear Medicine, PET/CT, Mammography, Bone Mineral Density (DXA), OPG dental scans, Lung Cancer Screening, Euflexxa joint injections, and PRP injections — across 10 clinics in the Hunter region and Greater Newcastle, New South Wales. Following November 2025 integration into the PRP Diagnostic Imaging network, the practice retains its brand and teams while gaining access to a 32-practice, 1,000+ professional NSW radiology network for sub-specialty expertise and advanced imaging services.
Is Alto Imaging a public or private company?
Alto Imaging is a private company. It is classified as corporate owned and is currently acquired.
When was Alto Imaging founded?
Alto Imaging was founded in -1. It employs 11 to 50 people.
Where is Alto Imaging based?
Alto Imaging is headquartered in Glendale, Australia, in the Oceania region.
How does Alto Imaging make money?
Two revenue lines are on record. Diagnostic Imaging Services are the primary driver. The others are therapeutic Injections.
Who are Alto Imaging's main competitors?
Direct peers on record are Akumin, Integral Diagnostics, PRP Diagnostic Imaging and Capitol Health. Broad incumbents are I-MED Radiology Network, Healius Limited, Radiology Partners, Sonic Healthcare and Unilabs. InHealth is listed as a regional player.
Does Alto Imaging have an API?
No public API is recorded for Alto Imaging.
What industry is Alto Imaging in?
Alto Imaging's product category is Diagnostic Imaging Services. Its primary akta.pro industry code is HLAFAKAA, Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound), with a secondary code of HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology). Its NAICS code is 621512 and its SIC code is 8011.